Use of BCG in Immunotherapy of Superficial Bladder Cancer: Multicentric Investigation on Safety and Compliance

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

1992 • 756 citations

LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER

1992 • 285 citations

Gender- and Smoking-Related Bladder Cancer Risk

2001 • 264 citations

Gender differences in stage-adjusted bladder cancer survival

2000 • 230 citations

Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder

1999 • 176 citations

Cigar Smoking in Men and Risk of Death From Tobacco-Related Cancers

2000 • 166 citations

The prognostic role of gender in survival of adult cancer patients

1998 • 146 citations

Gender differences in stage distribution of bladder cancer

2000 • 138 citations

Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications.

1989 • 89 citations

Systemic Bacillus Calmette-Guérin Infection, ‘BCGitis’, in Patients Treated by Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer

1989 • 81 citations

Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder

1995 • 52 citations

Quality of life in patients undergoing bacille Calmette‐Guérin therapy for superficial bladder cancer

1996 • 39 citations

Local Toxicity Patterns Associated with lntravesical bacillus Calmette‐Guérin: A Southwest Oncology Group Study

1996 • 34 citations

Smoking and urological disease

1998 • 18 citations

In Reply: Re: The Quality of Life During Intravesical Bacillus Calmette-Guerin Therapy

1996 • 15 citations

[Retrospective survey of pharmacologic tolerance in the prevention of neoplastic recurrence of superficial urothelioma].

1992 • 2 citations